Trump administration to restrict government use of Kaspersky Lab software

The General Services Administration removed products manufactured by the Moscow, Russia-based cybersecurity firm Kaspersky Lab from its list of approved products for use by government agencies July 13, reports The Hill.

Kaspersky Lab, which has locations across the globe, develops and sells antivirus software. Under the updated list, no government agency will be able to procure Kaspersky Lab products using a GSA contract.

This week, Bloomberg Businessweek released information linking the company to Russian intelligence. In May, Kaspersky Lab issued a statement saying it had "no ties to any government."

U.S. officials have not released evidence of a connection between Kaspersky Lab and Russian intelligence, although the FBI is reportedly investigating the company.

"GSA's priorities are to ensure the integrity and security of U.S. government systems and networks and evaluate products and services available on our contracts using supply chain risk management processes," a GSA spokesman told The Hill.

The restriction follows the Senate's push to ban Kaspersky Lab software in a June draft of the fiscal year 2018 Department of Defense budget.

More articles on health IT:

14M Verizon customers' data exposed, Verizon calls problem "overstated"

AMIA supports federal health IT research and development: 4 recommendations

Health IT Now to FDA: Interoperable PDMPs will curb opioid abuse


Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars